850 filings
4
NAVB
Navidea Biopharmaceuticals, Inc.
30 Dec 20
NAVIDEA BIOPHARMACEUTICALS / Malcolm G Witter ownership change
4:33pm
3
NAVB
Navidea Biopharmaceuticals, Inc.
30 Dec 20
NAVIDEA BIOPHARMACEUTICALS / Malcolm G Witter ownership change
4:32pm
SC 13D/A
NAVB
Navidea Biopharmaceuticals, Inc.
29 Dec 20
NAVIDEA BIOPHARMACEUTICALS / Scott John K Jr. ownership change
4:15pm
8-K
NAVB
Navidea Biopharmaceuticals, Inc.
28 Dec 20
Navidea Biopharmaceuticals Strengthens Board of Directors with the Appointment of Malcolm Witter
4:19pm
S-8
NAVB
Navidea Biopharmaceuticals, Inc.
13 Nov 20
Registration of securities for employees
4:30pm
8-K
85c6h87jsdn ifpdtw
12 Nov 20
Navidea Biopharmaceuticals Reports Third Quarter and Year-to-Date 2020 Financial Results
4:40pm
4
vjibx79sq38j42o
6 Nov 20
NAVIDEA BIOPHARMACEUTICALS / Joel H. Kaufman ownership change
5:08pm
3
yqzeuyhqv zn2p6p3n
6 Nov 20
NAVIDEA BIOPHARMACEUTICALS / Joel H. Kaufman ownership change
5:07pm
EFFECT
4dd6a
17 Sep 20
Notice of effectiveness
12:15am
CORRESP
owu7dcz 9ri
14 Sep 20
Correspondence with SEC
12:00am
8-K
5n7r 4e9uselfxi4
10 Sep 20
Submission of Matters to a Vote of Security Holders
4:02pm
4
vpnyc81ll45gizz8
2 Sep 20
NAVIDEA BIOPHARMACEUTICALS / John K Jr. Scott ownership change
9:47pm
424B5
v4ye4gdnumycc3d4edg
2 Sep 20
Prospectus supplement for primary offering
5:31pm
424B5
zkf0ltw
2 Sep 20
Prospectus supplement for primary offering
5:30pm
SC 13D/A
rtzrk5ab
2 Sep 20
NAVIDEA BIOPHARMACEUTICALS / Scott John K Jr. ownership change
5:18pm
8-K
l8q2pmmiigjo9cf
2 Sep 20
Entry into a Material Definitive Agreement
5:04pm
EFFECT
gdky3jtc0
2 Sep 20
Notice of effectiveness
12:15am
UPLOAD
8ofrpco ax
1 Sep 20
Letter from SEC
12:00am
POS AM
f4789er
28 Aug 20
Prospectus update (post-effective amendment)
8:18am